In the BioHarmony Drug Report Database

"Preview" Icon

Doravirine

Pifeltro (doravirine) is a small molecule pharmaceutical. Doravirine was first approved as Pifeltro on 2018-08-30. It is used to treat hiv-1 in the USA. It has been approved in Europe to treat HIV infections. Delstrigo’s patent is valid until 2031-10-07 (FDA).

 

Trade Name

 

Pifeltro
 

Common Name

 

doravirine
 

ChEMBL ID

 

CHEMBL2364608
 

Indication

 

hiv infections, hiv-1
 

Drug Class

 

Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives

Image (chem structure or protein)

Doravirine structure rendering